A partnership between Colossal and a conservation biotechnology platform aims to rescue the Tasmanian devil from a deadly contagious cancer that has caused an alarming 80% decrease in the population across Tasmania. This initiative combines Colossal's marsupial de-extinction technology with conservation efforts to combat the devastating impact of the disease. The collaboration, based in Dallas and Hobart, Australia, marks a significant step towards preserving the Tasmanian devil population.